Definition of the Bleeding Tendency in Factor XI-Deficient Kindreds–A Clinical and Laboratory Study

Summary

Individuals with severe factor XI deficiency are prone to excessive bleeding after injury or surgery, but the existence of a haemorrhagic tendency in partial factor XI deficiency is controversial. In this study, 172 members of 30 kindreds (20 non-Jewish) transmitting factor XI deficiency in North West England were interviewed and a bleeding history questionnaire completed. Blood was taken for coagulation assays. The questionnaires were categorised independently by two assessors to determine presence or absence of a bleeding tendency, in the absence of information about the factor XI level or family history. Analysis shows that 48% of heterozygotes have a bleeding tendency. Eighteen (60%) families came to attention because of bleeding problems in heterozygotes. Comparison of histories between partially deficient and non-deficient individuals demonstrated a higher incidence of menstrual problems, an increase in significant bruising, and an increased likelihood of excessive bleeding after tonsillectomy and dental extractions.

The incidence of von Willebrand’s disease was not increased, but individuals with heterozygous factor XI deficiency who were bleeders tended to have lower levels of factor VIIIc and von Willebrand factor, and were more commonly of blood group 0. These features may contribute to the bleeding tendency. There was no evidence of alteration in factor VII activity (as defined by the ratio of activity to antigen) between the bleeders and non-bleeders.

This is convincing evidence for abnormal bleeding in factor XI deficiency which is not confined to severely deficient patients.

• References

• 1 Rosenthal RL, Dreskin OH, Rosenthal N. New Hemophilia-like disease caused by deficiency of a third plasma thromboplastin factor. Proc Soc Exp Biol Med 1953; 82: 171-174
• 2 Seligsohn U. High gene frequency of factor XI (PTA) deficiency in Ashkenazi jews. Blood 1978; 51: 1223-1228
• 3 Saito H, Ratnoff OD, Bouma BN, Seligsohn U. Failure to detect variant (CRM+) plasma thromboplastin antecedent (factor XI) molecules in hereditary plasma thromboplastin antecedent deficiency: a study of 125 patients of several ethnic backgrounds. J Lab Clin Med 1985; 106: 718-722
• 4 Hancock JF, Wieland K, Pugh RE, Martinowitz U, Schulman S, Kakkar VV, Kernoff PB A, Cooper DN. A molecular genetic study of factor XI deficiency. Blood 1991; 77: 1942-1948
• 5 Leiba H, Ramot B, Many A. Heredity and coagulation studies in ten families with factor XI (plasma thromboplastin antecedent) deficiency. Br J Haematol 1995; 11: 654-665
• 6 Rapaport SI, Proctor RR, Patch MJ, Yettra M. The mode of inheritance of PTA deficiency: evidence for the existence of major PTA deficiency and minor PTA deficiency. Blood 1961; 18: 149-165
• 7 Mammen EF. Congenital coagulation disorders – Factor XI deficiency. Semin Thromb Haemost 1983; 9 (01) 34-35
• 8 Edson JR, White JG, Krivit W. The enigma of severe factor XI deficiency without hemorrhagic symptoms. Thromb Diath Haemorrh 1967; 18: 324-348
• 9 Egeberg O. A family with antihemophilic C factor (AHC = Plasma thromboplastin antecedent) deficiency without bleeding tendency. Scand J Clin Lab Invest 1962; 14: 478-486
• 10 Ragni MV, Sinha D, Seaman F, Lewis JH, Spero JA, Walsh PN. Comparison of bleeding tendency, factor XI coagulant activity, and factor XI antigen in 25 factor Xl-deficient kindreds. Blood 1985; 65: 719-724
• 11 Bolton-Maggs PH B, Young Wan-Yin B, McGraw AH, Slack J, Kernoff PB A. Inheritance and bleeding in factor XI deficiency. Br J Haematol 1988; 69: 521-528
• 12 Litz CE, Swaim WR, Dalmasso AP. Factor XI deficiency: genetic and clinical studies of a single kindred. Am J Hematol 1988; 28: 8-12
• 13 Lian EC-Y, Deykin D, Harkness DR. Combined deficiencies of factor VIII (AHF) and factor XI (PTA). Am J Hematol 1976; 1: 319-324
• 14 Chediak J, Lambert E, Johnson El, Telfer MC. Combined severe factor XI deficiency and von Willebrand’s disease. Am J Clin Pathol 1980; 74: 108-114
• 15 Tavori S, Brenner B, Tatarsky I. The effect of combined factor XI deficiency with von Willebrand factor abnormalities on haemorrhagic diathesis. Thromb Haemost 1990; 63: 36-38
• 16 Brody JI. Prolonged bleeding times with factor IX and XI deficiency (von Willebrand syndromes). Am J Med Sci 1975; 269: 19-24
• 17 Karaca M, Nilsson IM. PTA (Factor XI) deficiency and prolonged bleeding time. Act Med Scand 1972; 192: 171-176
• 18 Winter M, Needham J, Barkhan P. Factor XI deficiency and a platelet defect. Haemostasis 1983; 13: 83-88
• 19 Mannhalter C, Hellstem P, Deutsch E. Identification of a defective factor XI cross-reacting material in a factor XI deficient patient. Blood 1987; 70: 31-37
• 20 Asakai R, Chung DW, Davie EW, Seligsohn U. Factor XI deficiency in Ashkenazi jews in Israel. N Engl J Med 1991; 325: 153-158
• 21 Miller BC, Hultin MB, Jesty J. Altered factor VII activity in hemophilia. Blood 1985; 65: 845-849
• 22 Rosenthal RL, Dreskin OH, Rosenthal N. Plasma thromboplastin antecedent (PTA) deficiency: clinical, coagulation, therapeutic and hereditary aspects of a new hemophilia-like disease. Blood 1955; 10: 120-131
• 23 Cavins JA, Wall RL. Clinical and laboratory studies of plasma thromboplastin antecedent deficiency (PTA). Am J Med 1960; 444-448
• 24 Conrad FG, Breneman WL, Grisham DB. A clinical evaluation of plasma thromboplastin antecedent (PTA) deficiency. Ann Int Med 1965; 62: 885-898
• 25 Forbes CD, Madhok R. Genetic disorders of blood coagulation: clinical presentation and management. In: Disorders of Hemostasis. Ratnoff OD, Forbes CD. eds. WB Saunders; Philadelphia: 1991. Ch 5: pp 141-202
• 26 Kelly TE. Autosomal dominant and recessive traits. In: Clinical Genetics and Genetic Counselling, 2nd Edition. Year Book Medical Publishers Inc.; Chicago: 1986. Ch 4: p 67
• 27 Ohkubo Y, O’Brien DP, Kanehiro T, Fukui H, Tuddenham EG D. Characterization of a panel of monoclonal antibodies to human coagulation factor XI and detection of factor XI in Hep G2 cell conditioned medium. Thromb Haemost 1990; 63: 417-423
• 28 Machin SJ, Mackie IJ. Von Willebrand factor assay. In: Laboratory Haematology. An account of laboratory techniques Chanarin I. (ed). Churchill-Livingstone; 1989. pp 309-310
• 29 Campbell MJ, Machin D. Relative (receiver) operating characteristics. In: Medical Statistics. A commonsense approach John Wiley and Sons, Chichester; UK: 1990. pp 36-38
• 30 Bolton-Maggs PH B, Lloyd J, Wensley RT, Tuddenham EG D. Genetic analysis of 27 kindreds with factor XI deficiency from North West England. International Society of Haematology 1992. Abstract 511. p 131 Blackwell Scientific Publications;
• 31 Phillips LL, Hyman GA, Rosenthal RL. Prolonged post-operative bleeding in a patient with factor XI (PTA) deficiency. Ann Surg 1995; 162: 37-42
• 32 Bolton-Maggs PH B, Wensley RT, Kernoff PB A, Kasper CK, Winkelman L, Lane RS, Smith JK. Production and therapeutic use of a factor XI concentrate from plasma. Thromb Haemost 1992; 67: 314-319
• 33 Eikenboom JC J, Rosendaal FR, Briët E. History taking in the diagnosis of bleeding disorders. Thromb Haemost 1991; 65 (08) 1047
• 34 Pearson RW, Triplett DA. Factor XI assay results in the CAP survey. 1981; Am J Clin Path 1982; 78 S 615-620
• 35 Henry AI, Rosenthal RL. Spontaneous hemorrhages caused by plasma thromboplastin antecedent deficiency. JAMA 1956; 162: 727-729
• 36 Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol 1984; 149: 788-793
• 37 Rees MC P, Turnbull AC. Menstrual disorders – an overview. Clin Obstet Gynaecol 1989; 13: 217-226
• 38 Iles S, Gath S. Psychological problems and uterine bleeding. Clin Obstet Gynaecol 1989; 3: 375-389
• 39 Cox Gill J, Endres-Brooks. Bauer PJ, Marks WJ, Montgomery RR. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1997; 69: 1691-1695
• 40 Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood 1987; 69: 454-459
• 41 Berliner SA, Seligsohn U, Zivelin A, Zwang E, Sofferman G. A relatively high frequency of severe (type III) von Willebrand’s disease in Israel. Brit J Haematol 1986; 62: 535-543
• 42 Wildgoose P, Nemerson Y, Hansen LL, Nielsen FE, Glazer S, Hedner U. Measurement of basal levels of factor VIIa in hemophilia A and B patients. Blood 1992; 80: 25-28